In this way, IL-17 expression in tumors is associated not just with tumor invasiveness but also with increased VEGF expression, which was observed in our study in the later steps of tumor regrowth after resection, suggesting an increased vascularity in regrown GBM tumors. The gene discussed is IL17A; the disease is glioblastoma.